Atea Pharmaceuticals, Inc. (AVIR) Net income 2018–2025
Atea Pharmaceuticals, Inc. (AVIR) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$158.0MFY2025 · since FY2018: -$9.1M → -$158.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$158.0M | +6.0% |
| FY2024 | -$168.0M | -23.5% |
| FY2023 | -$136.0M | -17.2% |
| FY2022 | -$116.0M | -195.9% |
| FY2021 | $121.0M | +1205.3% |
| FY2020 | -$10.9M | +22.0% |
| FY2019 | -$14.0M | -54.8% |
| FY2018 | -$9.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice